Cargando…

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen de...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandl, Markus, Lieberum, Maria- Katharina, Dunst, Juergen, Depping, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647475/
https://www.ncbi.nlm.nih.gov/pubmed/26572229
http://dx.doi.org/10.1186/s13014-015-0539-9
_version_ 1782401106845892608
author Mandl, Markus
Lieberum, Maria- Katharina
Dunst, Juergen
Depping, Reinhard
author_facet Mandl, Markus
Lieberum, Maria- Katharina
Dunst, Juergen
Depping, Reinhard
author_sort Mandl, Markus
collection PubMed
description BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen deprivation and facilitates tumour progression. The subunits HIF-1α and ARNT are key players within this pathway. HIF-1α is regulated in an oxygen-dependent manner whereas ARNT is considered to be constitutively expressed. However, there is mounting evidence that certain tumour cells are capable to elevate ARNT in hypoxia which suggests a survival benefit. Therefore the objective of this study was to elucidate effects of an altered ARNT expression level on the cellular response to radiation. METHODS: Different human cell lines (Hep3B, MCF-7, 786-Owt, 786-Ovhl, RCC4wt and RCC4vhl) originating from various tumour entities (Hepatocellular carcinoma, breast cancer and renal cell carcinoma respectively) were X-irradiated using a conventional linear accelerator. Knockdown of ARNT expression was achieved by transient siRNA transfection. Complementary experiments were performed by forced ARNT overexpression using appropriate plasmids. Presence/absence of ARNT protein was confirmed by Western blot analysis. Clonogenic survival assays were performed in order to determine cellular survival post irradiation. Statistical comparison of two groups was achieved by the unpaired t-test. RESULTS: The results of this study indicate that ARNT depletion renders tumour cells susceptible to radiation whereas overexpression of this transcription factor confers radioresistance. CONCLUSIONS: These findings provide evidence to consider ARNT as a drug target and as a predictive marker in clinical applications concerning the response to radiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0539-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4647475
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46474752015-11-18 The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment Mandl, Markus Lieberum, Maria- Katharina Dunst, Juergen Depping, Reinhard Radiat Oncol Research BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen deprivation and facilitates tumour progression. The subunits HIF-1α and ARNT are key players within this pathway. HIF-1α is regulated in an oxygen-dependent manner whereas ARNT is considered to be constitutively expressed. However, there is mounting evidence that certain tumour cells are capable to elevate ARNT in hypoxia which suggests a survival benefit. Therefore the objective of this study was to elucidate effects of an altered ARNT expression level on the cellular response to radiation. METHODS: Different human cell lines (Hep3B, MCF-7, 786-Owt, 786-Ovhl, RCC4wt and RCC4vhl) originating from various tumour entities (Hepatocellular carcinoma, breast cancer and renal cell carcinoma respectively) were X-irradiated using a conventional linear accelerator. Knockdown of ARNT expression was achieved by transient siRNA transfection. Complementary experiments were performed by forced ARNT overexpression using appropriate plasmids. Presence/absence of ARNT protein was confirmed by Western blot analysis. Clonogenic survival assays were performed in order to determine cellular survival post irradiation. Statistical comparison of two groups was achieved by the unpaired t-test. RESULTS: The results of this study indicate that ARNT depletion renders tumour cells susceptible to radiation whereas overexpression of this transcription factor confers radioresistance. CONCLUSIONS: These findings provide evidence to consider ARNT as a drug target and as a predictive marker in clinical applications concerning the response to radiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0539-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-16 /pmc/articles/PMC4647475/ /pubmed/26572229 http://dx.doi.org/10.1186/s13014-015-0539-9 Text en © Mandl et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mandl, Markus
Lieberum, Maria- Katharina
Dunst, Juergen
Depping, Reinhard
The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title_full The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title_fullStr The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title_full_unstemmed The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title_short The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
title_sort expression level of the transcription factor aryl hydrocarbon receptor nuclear translocator (arnt) determines cellular survival after radiation treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647475/
https://www.ncbi.nlm.nih.gov/pubmed/26572229
http://dx.doi.org/10.1186/s13014-015-0539-9
work_keys_str_mv AT mandlmarkus theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT lieberummariakatharina theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT dunstjuergen theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT deppingreinhard theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT mandlmarkus expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT lieberummariakatharina expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT dunstjuergen expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment
AT deppingreinhard expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment